A study by UNIGE, in collaboration with ETH Zurich, has significantly improved the accuracy of a noninvasive brain ...

A study by UNIGE, in collaboration with ETH Zurich, has significantly improved the accuracy of a non-invasive brain ...

Accepted abstracts showcase Nexalin’s proprietary DIFS™ 15 mA 77.5 Hz treatment platform and clinical improvements across ...

Excessive daytime sleepiness (EDS) poses a significant clinical challenge, characterized by an increase need for sleep and intrusive sleep episodes, severely impacting daily functioning and overall ...

Deep brain stimulation (DBS) of the globus pallidus internus (GPi) is an established treatment for dystonia, yet the neurophysiological mechanisms underlying frequency-dependent effects remain poorly ...

Being able to noninvasively stimulate the deep brain without stimulating shallow regions is a key goal of non-invasive neurostimulation. Transcranial electrical stimulation (TES) is commonly used for ...

Deep brain stimulation—implants in the brain that act as a kind of "pacemaker"—has led to clinical improvements in half of the participants with treatment-resistant severe depression in an open-label ...

DEEP brain stimulation may improve quality of life in treatment-refractory OCD, but social and independence challenges often ...

Researchers have developed a noninvasive way to reduce movement problems in people with Parkinson’s disease by applying ...

Newly issued U.S. patent expected to provide core intellectual property protection through 2042, further strengthening Nexalin’s proprietary position in non-invasive frequency-based deep-brain ...

Please provide your email address to receive an email when new articles are posted on . Results from a clinical trial examining intracranial stimulation using a novel device in those with mild ...

Mayo Clinic researchers have found a new way to more precisely detect and monitor brain cell activity during deep brain stimulation, a common treatment for movement disorders such as Parkinson's ...